Connect Sign In
3004314
Neuron Specific Enolase, CSF
NSE C
Ordering Recommendation
Use to detect neuron specific enolase, which may be a nonspecific marker of neuronal damage.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
CSF.
Specimen Preparation
Separate from cells within 1 hour of collection. Transfer 0.5 mL CSF to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport Temperature
Refrigerated
Unacceptable Conditions
Hemolyzed specimens.
Remarks
Stability
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Methodology
Quantitative Immunoassay
Performed
Mon, Wed, Fri
Reported
1-8 days
Reference Interval
Less than or equal to 21.5 ng/mL
Interpretive Data
This test is performed using the BRAHMS NSE Kryptor Immunoassay. Results obtained with different methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
86316
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3004315 | Neuron Specific Enolase_CSF | 47053-4 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- NSE
Neuron Specific Enolase, CSF
